Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: --
326,70 DKK
Kurs
Kurs
-1,66%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
464,60 DKK
52 Wochen Hoch
52 Wochen Hoch
- Eher Negativ
- Seit dem 30.06.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 326,70 285 | 326,70 | 285 | 12,710567 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 326,70 325 | 326,70 | 325 | 0,459418 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 326,70 305 | 326,70 | 305 | 6,584992 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 326,70 300 | 326,70 | 300 | 8,116386 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 326,70 175 | 326,70 | 175 | 46,401225 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 290 | 326,70 | 290 | 11,179173 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 326,70 | 326,70 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 326,70 300 | 326,70 | 300 | 8,116386 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 326,70 332 | 326,70 | 332 | 1,684533 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 326,70 263 | 326,70 | 263 | 19,448698 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 326,70 175 | 326,70 | 175 | 46,401225 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 326,70 300 | 326,70 | 300 | 8,116386 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 275 | 326,70 | 275 | 15,773354 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 326,70 332 | 326,70 | 332 | 1,684533 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 326,70 263 | 326,70 | 263 | 19,448698 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 326,70 275 | 326,70 | 275 | 15,773354 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 326,70 300 | 326,70 | 300 | 8,116386 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 326,70 260 | 326,70 | 260 | 20,367534 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 326,70 332 | 326,70 | 332 | 1,684533 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 326,70 275 | 326,70 | 275 | 15,773354 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 326,70 275 | 326,70 | 275 | 15,773354 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 326,70 250 | 326,70 | 250 | 23,430322 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 326,70 340 | 326,70 | 340 | 4,134763 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 326,70 275 | 326,70 | 275 | 15,773354 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 326,70 332 | 326,70 | 332 | 1,684533 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 326,70 475 | 326,70 | 475 | 45,482389 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 326,70 332 | 326,70 | 332 | 1,684533 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 326,70 390 | 326,70 | 390 | 19,448698 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 326,70 436 | 326,70 | 436 | 33,537519 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 326,70 415 | 326,70 | 415 | 27,105666 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 326,70 270 | 326,70 | 270 | 17,304747 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 326,70 390 | 326,70 | 390 | 19,448698 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 326,70 390 | 326,70 | 390 | 19,448698 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 326,70 415 | 326,70 | 415 | 27,105666 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 326,70 475 | 326,70 | 475 | 45,482389 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 326,70 390 | 326,70 | 390 | 19,448698 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 326,70 360 | 326,70 | 360 | 10,260337 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 326,70 475 | 326,70 | 475 | 45,482389 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 326,70 475 | 326,70 | 475 | 45,482389 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 326,70 295 | 326,70 | 295 | 9,647779 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 326,70 295 | 326,70 | 295 | 9,647779 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 326,70 350 | 326,70 | 350 | 7,19755 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 326,70 352 | 326,70 | 352 | 7,810107 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 326,70 400 | 326,70 | 400 | 22,511485 | BERENBERG |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M